Non-glomerular Tip Lesion Focal Segmental Glomerulosclerosis as a Negative Predictor in Idiopathic Membranous Nephropathy

Abstract

Objective

To assess the significance of focal segmental glomerulosclerosis (FSGS) variants on clinicopathological characteristics and short-term outcomes in idiopathic membranous nephropathy (IMN) patients.

Methods

The clinicopathological data of 146 IMN patients diagnosed between December 2016 and March 2019 in our center were collected and analyzed. These patients were divided into the pure IMN group, IMN with glomerular tip lesion (GTL) group, and IMN with non-GTL FSGS group.

Results

The IMN with non-GTL FSGS and IMN with GTL groups both had higher proportions of patients with hypertension, lower serum albumin, and severe proteinuria, while the IMN with non-GTL FSGS group additionally showed higher blood pressure and serum cholesterol, and lower serum IgG than the IMN group (all P<0.05). As for pathology, the IMN with non-GTL FSGS group had higher proportions of patients with acute tubular injury and moderate to severe chronic injuries than the IMN group (all P<0.05). In the IMN, IMN with GTL, and IMN with non-GTL FSGS groups, the overall one-year remission rates were 81.6%, 76%, and 58.8%, respectively. Furthermore, the IMN with non-GTL FSGS group showed the lowest cumulative incidence to reach remission within one year. Multivariate Cox logistic analysis demonstrated that higher level of serum anti-M-type phospholipase A2 receptor antibody and the existence of non-GTL FSGS lesion were independent predictors for no remission in IMN patients.

Conclusion

The non-GTL FSGS lesion was a novel negative predictor in IMN and should be taken into account in the management of IMN.

Keywords

idiopathic membranous nephropathy / focal segmental glomerulosclerosis / glomerular tip lesion

References

[1] PolancoN, GutiérrezE, CovarsíA, et al.. Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. J Am Soc Nephrol, 2010, 21(4): 697-704

[2] CattranDC. Idiopathic membranous glomerulonephritis. Kidney Int, 2001, 59(5): 1983-1994

[3] HouJH, ZhuHX, ZhouML, et al.. Changes in the Spectrum of Kidney Diseases: An Analysis of 40,759 Biopsy-Proven Cases from 2003 to 2014 in China. Kidney Dis (Basel), 2018, 4(1): 10-19

[4] HladunewichMA, TroyanovS, CalafatiJ, et al.. The natural history of the non-nephrotic membranous nephropathy patient. Clin J Am Soc Nephrol, 2009, 4(9): 1417-1422

[5] ZuoK, WuY, LiSJ, et al.. Long-term outcome and prognostic factors of idiopathic membranous nephropathy in the Chinese population. Clin Nephrol, 2013, 79(6): 445-453

[6] HorvaticI, LjubanovicDG, BulimbasicS, et al.. Prognostic significance of glomerular and tubulointerstitial morphometry in idiopathic membranous nephropathy. Pathol Res Pract, 2012, 208(11): 662-667

[7] LiJ, ChenB, GaoC, et al.. Clinical and pathological features of idiopathic membranous nephropathy with focal segmental sclerosis. BMC Nephrol, 2019, 20(1): 467

[8] HoxhaE, HarendzaS, PinnschmidtH, et al.. M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy. Clin J Am Soc Nephrol, 2014, 9(11): 1883-1890

[9] ChengW, SunL, DongH, et al.. Clinicopathologic characteristic and prognosis in idiopathic membranous nephropathy patients with focal segmental sclerosis lesion: A retrospective observational study. Medicine (Baltimore), 2021, 100(3): e23988

[10] ShiikiH, SaitoT, NishitaniY, et al.. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int, 2004, 65(4): 1400-1407

[11] SchieppatiA, MosconiL, PernaA, et al.. Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med, 1993, 329(2): 85-89

[12] HeHG, WuCQ, YeK, et al.. Focal segmental glomerulosclerosis, excluding atypical lesion, is a predictor of renal outcome in patients with membranous nephropathy: a retrospective analysis of 716 cases. BMC Nephrol, 2019, 20(1): 328

[13] SprangersB, BombackAS, CohenSD, et al.. Idiopathic membranous nephropathy: clinical and histologic prognostic features and treatment patterns over time at a tertiary referral center. Am J Nephrol, 2012, 36(1): 78-89

[14] HeeringaSF, BrantenAJ, DeegensJK, et al.. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy. Nephrol Dial Transplant, 2007, 22(8): 2201-2207

[15] ChenY, TangL, FengZ, et al.. Pathological predictors of renal outcomes in nephrotic idiopathic membranous nephropathy with decreased renal function. J Nephrol, 2014, 27(3): 307-316

[16] MarxBE, MarxM. Prediction in idiopathic membranous nephropathy. Kidney Int, 1999, 56(2): 666-673

[17] DumoulinA, HillGS, MontsenyJJ, et al.. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis. Am J Kidney Dis, 2003, 41(1): 38-48

[18] HowieAJ, BrewerDB. The glomerular tip lesion: a previously undescribed type of segmental glomerular abnormality. J Pathol, 1984, 142(3): 205-220

[19] HowieAJ. Changes at the glomerular tip: a feature of membranous nephropathy and other disorders associated with proteinuria. J Pathol, 1986, 150(1): 13-20

[20] LeeSJ, HowieAJ. Changes at the glomerulo-tubular junction in renal transplants. J Pathol, 1988, 156(4): 311-318

[21] StokesMB, MarkowitzGS, LinJ, et al.. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum. Kidney Int, 2004, 65(5): 1690-1702

[22] ThomasDB, FranceschiniN, HoganSL, et al.. Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int, 2006, 69(5): 920-926

[23] DeegensJK, SteenbergenEJ, BormGF, et al.. Pathological variants of focal segmental glomerulosclerosis in an adult Dutch population—epidemiology and outcome. Nephrol Dial Transplant, 2008, 23(1): 186-192

[24] FotheringhamJ, CampbellMJ, FogartyDG, et al.. Estimated albumin excretion rate versus urine albumin-creatinine ratio for the estimation of measured albumin excretion rate: derivation and validation of an estimated albumin excretion rate equation. Am J Kidney Dis, 2014, 63(3): 405-414

[25] MaYC, ZuoL, ChenJH, et al.. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol, 2006, 17(10): 2937-2944

[26] EhrenreichT, ChurgJ. Pathology of membranous nephropathy. Pathol Annu, 1968, 3: 145-189

[27] GuptaR, SharmaA, MahantaPJ, et al.. Focal segmental glomerulosclerosis in idiopathic membranous glomerulonephritis: a clinico-pathological and stereological study. Nephrol Dial Transplant, 2010, 25(2): 444-449

[28] HaasM, YousefzadehN. Glomerular tip lesion in minimal change nephropathy: a study of autopsies before 1950. Am J Kidney Dis, 2002, 39(6): 1168-1175

[29] LeeHS, KohHI. Nature of progressive glomerulosclerosis in human membranous nephropathy. Clin Nephrol, 1993, 39(1): 7-16

[30] TroyanovS, WallCA, MillerJA, et al.. Idiopathic membranous nephropathy: definition and relevance of a partial remission. Kidney Int, 2004, 66(3): 1199-1205

[31] ThompsonA, CattranDC, BlankM, et al.. Complete and Partial Remission as Surrogate End Points in Membranous Nephropathy. J Am Soc Nephrol, 2015, 26(12): 2930-2937

[32] WangMK, WhiteC, AkbariA, et al.. Utilizing Estimated Creatinine Excretion to Improve the Performance of Spot Urine Samples for the Determination of Proteinuria in Kidney Transplant Recipients. PLoS One, 2016, 11(12): e0166547